Featured Research

from universities, journals, and other organizations

Purified blood stem cells improve success of bone marrow transplants in mice, study shows

Date:
August 3, 2010
Source:
Stanford University Medical Center
Summary:
Researchers have challenged decades of accepted wisdom about bone marrow transplantation with a new study showing that mice receiving purified blood stem cells are less prone to complications than mice receiving stem cells plus purified T cells.

Researchers at the Stanford University School of Medicine have challenged decades of accepted wisdom about bone marrow transplantation with a new study showing that mice receiving purified blood stem cells are less prone to complications than mice receiving stem cells plus purified T cells.

The study, led by Judith Shizuru, MD, PhD, associate professor of medicine, will be published online Aug. 2 in the Proceedings of the National Academy of Sciences.

Bone marrow transplantation has long been a powerful therapy in combating cancer and other disorders, but it also involves serious risks that make physicians wary. Patients getting bone marrow transplants must first be given powerful drugs or radiation treatments that wipe out their own bone marrow and immune cells, leaving them vulnerable to life-threatening infections.

The patient's supply of blood and immune stem cells is then replenished by bone marrow from a donor, but this bone marrow also contains mature immune cells called T cells that can see the patient's tissues as immunologically foreign. T cells that react against patient tissues cause a disorder called graft versus host disease, or GVHD, which can severely damage the patient's body.

Conventional wisdom among transplantation specialists has been that the bone marrow transplant should contain some T cells from the donor. Although the presence of mature donor T cells is known to cause GVHD, it is generally believed that these T cells can help protect the patient from infectious disease and fight cancer until the transplanted stem cells can mature into a new immune system. It is also thought that the presence of mature T cells decreases the chance that the patient will reject the graft.

"People think that T cells are a necessary evil because they help with engraftment and immune reconstitution," Shizuru said. For these reasons, patients are not given pure blood-forming stem cells as part of current therapy.

The new research by Shizuru, lead author, and research associate Antonia Mueller, MD, and their colleagues calls into question those assumptions. When they compared mice given pure stem cells with mice given a mixture of stem cells and mature T cells, they found that the mice given pure stem cells were better at forming new blood cells and faster in regenerating lymphoid tissues. T cells from the donor seemed to work against the grafted stem cells and inhibit their maturation into mature immune cells. Furthermore, Shizuru said follow-up studies showed that the donor's T cells did not help eradicate pathogens.

The current research expands on work done by Shizuru last year, in which she and her colleagues compared the effectiveness of purified stem cells with unmanipulated bone marrow cells containing low levels of T cells.

In the new study, Shizuru and her colleagues took a more precise look at the action of the mature T cells by comparing how well both groups of mice were able to regenerate bone marrow, blood and lymphoid tissues in the early post-transplant period (within one week) up through one year after transplantation.

Although the work was done in mice, Shizuru believes the results will be medically pertinent. "In our studies we tried to replicate the human system, and I believe what we have found is applicable to humans," she said.

The paper's other co-authors include graduate student Jessica Linderman; postdoctoral scholar Mareike Florek, MD; and David Miklos, MD, PhD, assistant professor of medicine.

The study was funded by the National Institutes of Health, the German Research Foundation and the Snyder Foundation.


Story Source:

The above story is based on materials provided by Stanford University Medical Center. The original article was written by Christopher Vaughan. Note: Materials may be edited for content and length.


Journal References:

  1. Antonia M. S. Mόller, Jessica A. Linderman, Mareike Florek, David Miklos, and Judith A. Shizuru. Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation. Proceedings of the National Academy of Sciences, 2010; DOI: 10.1073/pnas.1009220107
  2. Antonia M. S. Mόller, Jessica A. Linderman, Mareike Florek, David Miklos, and Judith A. Shizuru. Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation. Proceedings of the National Academy of Sciences,

Cite This Page:

Stanford University Medical Center. "Purified blood stem cells improve success of bone marrow transplants in mice, study shows." ScienceDaily. ScienceDaily, 3 August 2010. <www.sciencedaily.com/releases/2010/08/100802151313.htm>.
Stanford University Medical Center. (2010, August 3). Purified blood stem cells improve success of bone marrow transplants in mice, study shows. ScienceDaily. Retrieved September 19, 2014 from www.sciencedaily.com/releases/2010/08/100802151313.htm
Stanford University Medical Center. "Purified blood stem cells improve success of bone marrow transplants in mice, study shows." ScienceDaily. www.sciencedaily.com/releases/2010/08/100802151313.htm (accessed September 19, 2014).

Share This



More Health & Medicine News

Friday, September 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) — The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) — A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) — Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) — As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins